6874 Federal Register / Vol. 81, No. 26 / Tuesday, February 9, 2016 / Notices 

chimpanzee and the social group in 

which the chimpanzee lives. 

Specifically, permissible research, as 

described in the ‘‘Standards of Care for 

Chimpanzees Held in the Federally 

Supported Chimpanzee Sanctuary 

System’’ at 42 CFR part 9, includes: 

• Visual observation; 

• Behavioral studies designed to 

improve the establishment and 

maintenance of social groups. These 

activities may cause stress as a result of 

novel interactions between chimpanzees 

and caregivers, but they are not 

considered invasive as long as they are 

intended to maximize the well-being of 

the chimpanzees; 

• Medical examinations as deemed 

necessary to oversee the health of the 

chimpanzees, in the least invasive 

manner possible. Collection of samples 

routinely obtained during a physical 

examination for processing during this 

time is also considered noninvasive 

since a separate event is not required; 

• Administration and evaluation of 

environmental enrichment used to 

promote the psychological well-being of 

the chimpanzees; and 

• Actions taken to provide essential 

medical treatment to an individual 

chimpanzee exhibiting symptoms of 

illness. This applies only to serious 

illness that cannot be treated while the 

chimpanzee remains within the colony. 

• Observational studies and 

collection of biomaterial in the wild 

without interfering with the chimpanzee 

is also permitted. 

These decisions apply to all new or 

competing renewals of grant 

applications, contract proposals, 

intramural protocols, and 3rd party 

projects. The NIH may issue future 

guidance about the permissible 

noninvasive research involving 

chimpanzees. Researchers are 

encouraged to contact their program 

officers for additional information or the 

Division of Program Coordination, 

Planning, and Strategic Initiatives at 

dpcpsi@od.nih.gov. 

The NIH’s decision to allow the 

support of noninvasive research 

involving the use of chimpanzees, as 

described in this notice, does not affect 

requirements for investigators and/or 

their institutions to obtain permits from 

the U.S. Fish and Wildlife Service, if 

applicable, nor does it affect the 

responsibility to meet all applicable 

veterinary, colony, and husbandry 

obligations. 

Dated: February 2, 2016. 

Lawrence A. Tabak, 

Deputy Director, National Institutes of Health. 

[FR Doc. 2016–02554 Filed 2–8–16; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Human Genome Research 

Institute; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Human 

Genome Research Institute Special Emphasis 

Panel, KOMP2 (Knockout Mouse 

Phenotyping Program). 

Date: March 3, 2016 

Time: 12:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: NHGRI, 5635FL, NHGRI Twinbrook 

Library, Fishers Lane, Rockville, MD 20852, 

(Telephone Conference Call). 

Contact Person: Lita Proctor, Ph.D., 

Extramural Research Programs Staff, Program 

Director, Human Microbiome Project, 

National Human Genome Research Institute, 

5635 Fishers Lane, Suite 4076, Bethesda, MD 

20892, 301 496–4550, proctorlm@

mail.nih.gov. 

Name of Committee: National Human 

Genome Research Institute Special Emphasis 

Panel, Sequencing Technology Special 

Emphasis Panel. 

Date: March 24, 2016. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crystal City Marriott at Reagan 

National Airport, 1999 Salon E & D, Jefferson 

Davis Highway, Arlington, VA 22202. 

Contact Person: Ken D. Nakamura, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Human Genome Research 

Institute, National Institutes of Health, 5635 

Fishers Lane, Suite 4076, MSC 9306, 

Rockville, MD 20852, 301–402–0838, 

nakamurk@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.172, Human Genome 

Research, National Institutes of Health, HHS) 

Dated: February 4, 2016. 

Sylvia Neal, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2016–02538 Filed 2–8–16; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 30-Day 

Comment Request; Application Forms 

for the NIDA Summer Research 

Internship Program 

SUMMARY: Under the provisions of 

Section 3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Institutes of Health (NIH) has submitted 

to the Office of Management and Budget 

(OMB) a request for review and 

approval of the information collection 

listed below. This proposed information 

collection was previously published in 

the Federal Register on September 2, 

2015, Vol. 80, No. 170, on page 53164. 

No comments were received. The 

purpose of this notice is to allow an 

additional 30 days for public comment. 

The National Institute of Drug Abuse 

(NIDA), National Institutes of Health, 

may not conduct or sponsor, and the 

respondent is not required to respond 

to, an information collection that has 

been extended, revised, or implemented 

on or after October 1, 1995, unless it 

displays a currently valid OMB control 

number. 

Direct Comments to Omb: Written 

comments and/or suggestions regarding 

the item(s) contained in this notice, 

especially regarding the estimated 

public burden and associated response 

time, should be directed to the: Office 

of Management and Budget, Office of 

Regulatory Affairs, OIRA_submission@

omb.eop.gov or by fax to 202–395–6974, 

Attention: NIH Desk Officer. 

Comment Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 30 days of the date of 

this publication. 

FOR FURTHER INFORMATION CONTACT: To 

obtain a copy of the data collection 

plans and instruments, or request more 

information on the proposed program, 

contact: Albert Avila, Ph.D., Director, 

Office of Diversity and Health 

Disparities, NIDA, NIH, 6001 Executive 

Blvd., Room 3106, Rockville, MD 20852, 

or call non-toll-free number (301)–443– 

0441 or Email your request, including 

your address to: aavila@nida.nih.gov. 

Formal requests for additional plans and 

instruments must be requested in 

writing. 

Proposed Collection: NIDA Summer 

Research Internship Program 0925- 

Existing Collection in Use Without an 

OMB Control Number, National 

Institute on Drug Abuse (NIDA), 

National Institutes of Health (NIH). 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 81, No. 26 / Tuesday, February 9, 2016 / Notices 6875 

Need and Use of Information 

Collection: The NIDA Summer Research 

Internship program introduces high 

school and undergraduate students of 

underrepresented populations to 

substance abuse research through 

internships with NIDA grantees at 

universities across the United States and 

Puerto Rico. Students intern with NIDA 

principal investigators for 8–10 weeks 

during the summer. The internship 

experience may include laboratory 

experiments, formal courses, data 

collection, data analysis, patient 

recruitment, manuscript preparation, 

literature reviews and library research. 

This outreach and pipeline program 

exposes students interested in 

biomedical and behavioral research 

careers to cutting edge substance abuse 

research. 

This program fills a significant unmet 

need to encourage and support 

individuals from underrepresented 

groups to pursue careers in substance 

abuse research. The NIDA Summer 

Research Internship program offers a 

unique opportunity to increase the 

diversity and creativity of the 

biomedical research workforce by 

fostering the development of young 

talent through the creation of 

mentorship and training opportunities 

with premier substance abuse research 

laboratories around the country. 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

350. 

ESTIMATED ANNUALIZED BURDEN HOURS

Form name Type of respondent Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total annual 

burden hours 

Application Form ............................... High School Students ....................... 100 1 1 100 

Application Form ............................... Undergraduates ................................ 250 1 1 250 

Dated: February 2, 2016. 

Genevieve DeAlmeida-Morris, 

Project Clearance Liaison, NIDA, NIH. 

[FR Doc. 2016–02446 Filed 2–8–16; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Human Genome Research 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Inherited 

Disease Research Access Committee. 

Date: March 4, 2016. 

Time: 11:30 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Suite 

3049, 5635 Fishers Lane, Bethesda, MD 

20892, (Telephone Conference Call). 

Contact Person: Barbara J Thomas, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2218, 

MSC 7890, Bethesda, MD 20892, 301–435– 

0603, bthomas@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.172, Human Genome 

Research, National Institutes of Health, HHS) 

Dated: February 4, 2016. 

Sylvia Neal, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2016–02537 Filed 2–8–16; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Heart, Lung, and 

Blood Initial Review Group; Clinical Trials 

Review Committee. 

Date: March 3–4, 2016. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Residence Inn Bethesda, 7335 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Keary A. Cope, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review/DERA, National Heart, Lung, and 

Blood Institute, 6701 Rockledge Drive, Room 

7190, Bethesda, MD 20892–7924, 301–435– 

2222, copeka@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: February 3, 2016. 

Michelle Trout, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2016–02456 Filed 2–8–16; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

grant applications and the discussions 

could disclose confidential trade secrets 

or commercial property such as 

patentable material, and personal 

information concerning individuals 

mstockstill on DSK4VPTVN1PROD with NOTICES